来自MSN22 分钟
Citigroup Upgrades Glaukos (GKOS)
Fintel reports that on December 11, 2024, Citigroup upgraded their outlook for Glaukos (NYSE:GKOS) from Neutral to Buy.
Korea Joongang Daily on MSN30 分钟
GC Biopharma to acquire blood bank operator ABO Holdings for $96 million
GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.
Daily48 分钟
USFDA nod to Gland Pharma Vitamin K deficiency treatment drug
Hyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United ...
Gland Pharma shares zoom up to 5%: here's why
Gland Pharma shares soared up to 5 per cent in early trade after the US drug regulator approved the company's Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.